INTEZOR owner Contact Information online
from NPS Pharmaceuticals, Inc.
INTEZOR
US serial number:85150985
Application filling date:Oct. 12, 2010
Register:Principal
Mark type:Trademark
Status:Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Status date:Jun. 16, 2014
Publication date:Mar. 15, 2011
Abandoned date:Jun. 16, 2014
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Goods and services:For: Pharmaceutical preparations for the treatment or prevention of gastrointestinal disorders, diseases involving varying levels of calcium in cells and outside cells, endocrine disorders, and bone metabolism disorders
International Class(es): 005- Prima
Services:Pharmaceutical preparations for the treatment or prevention of gastrointestinal disorders
diseases involving varying levels of calcium in cells and outside cells
endocrine disorders
and bone metabolism disorders
Current owner owner name:NPS Pharmaceuticals, Inc.
Current owner owner address:550 Hills Drive, 3rd Floor
Bedminster,
NEW JERSEY
UNITED STATES
07921
Current owner legal entity type:CORPORATION
Current owner state or country:DELAWARE
Attorney name:Michael E. Mangelson
Attorney email:TM-SLC@stoel.com
Attorney docket number:50821/45
Attorney email authorized:Yes
Correspondent name address:MICHAEL E. MANGELSON
STOEL RIVES, LLP
201 S MAIN ST STE 1100
SALT LAKE CITY,
UTAH
UNITED STATES
84111-2208
Correspondent phone:801-578-6903
Correspondent email:TM-SLC@stoel.com
Correspondent fax:801-578-6999
Correspondent email authorized:Yes
Trademark staff tm attorney:RAPPAPORT, SETH A
Trademark staff law office assigned INTEZOR:LAW OFFICE 103
Latest trademarks
Popular owners
Glaxo Group Limited (174) JOHNSON & JOHNSON (136) Novartis AG (134) Millennium Pharmaceuticals, Inc. (54) Eli Lilly and Company (51) Windmill Health Products, LLC (47) Bayer Aktiengesellschaft (44) SANOFI (43) Pfizer Inc. (41) Wyeth LLC (41) Bristol-Myers Squibb Company (35) Forest Laboratories, Inc. (34) Vital Health Pharmaceuticals, Inc. (31) S. C. Johnson & Son, Inc. (29) Primary Investments Group Limited (28) MERCK SHARP & DOHME CORP. (27) Futurebiotics, LLC (26) MONSTER ENERGY COMPANY (19) Scott Riddell (17) Biocept, Inc. (16)Popular publication dates
Mar. 15, 2011 Mar. 08, 2011 Mar. 22, 2011 Nov. 16, 2010 Mar. 29, 2011 Apr. 19, 2011 Apr. 12, 2011 Oct. 19, 2010 Oct. 26, 2010 Apr. 26, 2011 Feb. 15, 2011 Oct. 05, 2010 Oct. 12, 2010 Jan. 25, 2011 Sep. 21, 2010 Jan. 11, 2011 Feb. 22, 2011 Nov. 23, 2010 Sep. 28, 2010 Apr. 05, 2011Similar brands
